| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/13/2011 | US20110009383 Method of treating mixed lineage leukemia gene-rearranged acute lymphoblastic leukemias |
| 01/13/2011 | US20110009382 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles |
| 01/13/2011 | US20110009381 Solubilized thiazolopyridines |
| 01/13/2011 | US20110009380 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 01/13/2011 | US20110009379 Indolinone compound |
| 01/13/2011 | US20110009378 Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy |
| 01/13/2011 | US20110009377 Azetidine derivatives, their preparation and their application in therapy |
| 01/13/2011 | US20110009376 Prophylactic or therapeutic agent for eye disease accompanied by optic nerve disorder |
| 01/13/2011 | US20110009375 Fusidic acid regimens for treatment of bacterial infections |
| 01/13/2011 | US20110009374 Method of wound healing and scar modulation |
| 01/13/2011 | US20110009373 Composition comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis |
| 01/13/2011 | US20110009372 Compounds and compositions |
| 01/13/2011 | US20110009371 Synthesis of tetracyclines and analogues thereof |
| 01/13/2011 | US20110009370 Method to enhance tissue regeneration |
| 01/13/2011 | US20110009369 Anti-influenza compounds |
| 01/13/2011 | US20110009368 Solid forms of tenofovir disoproxil |
| 01/13/2011 | US20110009367 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 01/13/2011 | US20110009366 Bicyclic pyrimidinones and uses thereof |
| 01/13/2011 | US20110009365 Derivatives of indole-2-carboxamides and of azaindole-2-carboxamides substituted with a silanyl group, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009364 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009363 Synthesis and biological activities of new tricyclic-bis-enones (tbes) |
| 01/13/2011 | US20110009362 Solubility-enhanced forms of aprepitant and pharmaceutical compositions thereof |
| 01/13/2011 | US20110009361 Design and selection of medicaments that modulate the function and activity of interleukin 13 |
| 01/13/2011 | US20110009360 Nutraceutical Composition and Methods for Preventing or Treating Multiple Sclerosis |
| 01/13/2011 | US20110009359 Use of non-digestible carbohydrates for improving intestinal microbiota |
| 01/13/2011 | US20110009358 Agent for suppressing glucose level increase, agent for suppressing body fat accumulation and food compound |
| 01/13/2011 | US20110009357 Lipid composition for improving brain function |
| 01/13/2011 | US20110009356 Novel phosphorus-containing prodrugs |
| 01/13/2011 | US20110009355 Azapeptide Derivatives |
| 01/13/2011 | US20110009354 5',-substituted adenosynes preparation thereof and use as inhibitors of s-adenosylmethionine decarboxylase |
| 01/13/2011 | US20110009353 Targeting cdk4 and cdk6 in cancer therapy |
| 01/13/2011 | US20110009352 Restorative agent for antibacterial peptide production ability |
| 01/13/2011 | US20110009351 Screening assay to identify correctors of protein trafficking defects |
| 01/13/2011 | US20110009349 Methods of maintaining or increasing growth or cognitive development |
| 01/13/2011 | US20110009348 Carbohydrate gel |
| 01/13/2011 | US20110009347 Combination therapy for the treatment of diabetes |
| 01/13/2011 | US20110009346 Methods and compositions for increasing the anaerobic working capacity in tissues |
| 01/13/2011 | US20110009343 Modulators of amyloid aggregation |
| 01/13/2011 | US20110009342 Uses of pdcd5 polypeptide for tumor chemotherapy and organ protection |
| 01/13/2011 | US20110009333 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 01/13/2011 | US20110009332 Therapeutic Treatment Of Wounds |
| 01/13/2011 | US20110009325 Crystalline forms of rapamycin analogs |
| 01/13/2011 | US20110009318 Transdermal Compositions and Methods for Treatment of Fibromyalgia and Chronic Fatigue Syndrome |
| 01/13/2011 | US20110008842 Novel chimeric tnf ligands |
| 01/13/2011 | US20110008486 Agent for suppressing glucose level increase, agent for suppressing body fat accumulation and food compound |
| 01/13/2011 | US20110008476 Methods of Treating or Preventing Inflammatory Diseases of the Intestinal Tract |
| 01/13/2011 | US20110008474 Topical Antifungal Composition |
| 01/13/2011 | US20110008472 Anti-methicillin-resistant staphylococcus aureus agent and anti-vancomycin-resistant enterococcus agent |
| 01/13/2011 | US20110008468 Uses of chemicals to modulate GSK-3 signaling for treatment of bipolar disorder and other brain disorders |
| 01/13/2011 | US20110008465 Sesquiterpene formulations, kits and methods of use thereof |
| 01/13/2011 | US20110008464 Methods and compositions for treating thyroid-related medical conditions with reduced folates |
| 01/13/2011 | US20110008461 Inhibitor scaffold for the inhibition of the enzyme phosphoenolpyruvate carboxykinase |
| 01/13/2011 | US20110008456 Controlled Release Corticosteroid Compositions and Methods for the Treatment of Otic Disorders |
| 01/13/2011 | US20110008454 Immediate release pharmaceutical granule compositions and a continuous process for making them |
| 01/13/2011 | US20110008453 Stable Corticosteroid Nanoparticulate Formulations And Methods For The Making And Use Thereof |
| 01/13/2011 | US20110008451 Compositions and methods for controlled delivery of inhibitory ribonucleic acids |
| 01/13/2011 | US20110008450 Slow Release Compositions |
| 01/13/2011 | US20110008447 Carrier comprising nanodiamond |
| 01/13/2011 | US20110008445 Suspension of ascorbic acid in glycerin and process for production thereof |
| 01/13/2011 | US20110008441 Thermoresponsive arginine-based hydrogels as biologic carriers |
| 01/13/2011 | US20110008440 Novel nanocompound materials with infrared, ultraviolet and visible electromagnetic radiation blocking properties and method for obtaining them |
| 01/13/2011 | US20110008439 Duloxetin composition |
| 01/13/2011 | US20110008436 Silk Fibroin Hydrogels and Uses Thereof |
| 01/13/2011 | US20110008435 Nanoparticulate and Controlled Release Compositions Comprising Aryl-Heterocyclic Compounds |
| 01/13/2011 | US20110008434 Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
| 01/13/2011 | US20110008432 Method for Treating a Patient in Need of Aspirin Therapy |
| 01/13/2011 | US20110008431 Therapeutic tablet for postherpetic neuralgia and method of treating postherpetic neuralgia |
| 01/13/2011 | US20110008430 Solid Pharmaceutical Dosage Form |
| 01/13/2011 | US20110008429 Anti-Retroviral Combination |
| 01/13/2011 | US20110008428 Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic |
| 01/13/2011 | US20110008426 Modified release pharmaceutical compositions comprising mycophenolate and processes thereof |
| 01/13/2011 | US20110008425 Treatment for Attention-Deficit Hyperactivity Disorder |
| 01/13/2011 | US20110008424 Sustained Release Solid Formulations and Methods of Manufacturing the Same |
| 01/13/2011 | US20110008418 Compositions and Methods for the Treatment of Cancer |
| 01/13/2011 | US20110008415 Novel lipophilic compositions and uses thereof |
| 01/13/2011 | US20110008413 Compositions and Methods of Topical Drug Delivery for the Treatment of Carpal Tunnel Syndrome |
| 01/13/2011 | US20110008412 Oral Formulations for 5-HT-Receptor Agonists, Uses and Methods of Treatment Employing The Same |
| 01/13/2011 | US20110008410 Pharmaceutical composition for treating malaria |
| 01/13/2011 | US20110008409 Pharmaceutical preparation containing a gestagen, and kit and method for treating endometriosis using the preparation |
| 01/13/2011 | US20110008408 Solid dosage form for treating headaches |
| 01/13/2011 | US20110008406 Silk Fibroin Hydrogels and Uses Thereof |
| 01/13/2011 | US20110008403 Medical antimicrobial composition and medical device comprising the same |
| 01/13/2011 | US20110008398 Medicated patch |
| 01/13/2011 | US20110008396 Compositions and methods for treating cardiovascular conditions |
| 01/13/2011 | US20110008395 Mixed micelles including amphipathic conjugates of rna agents, and uses thereof |
| 01/13/2011 | US20110008392 Vaccine targets and delivery systems for cryptosporidium |
| 01/13/2011 | US20110008374 Use of IL-1 Antagonists to Treat Gout |
| 01/13/2011 | US20110008373 Prodrugs of cc-1065 analogs |
| 01/13/2011 | US20110008372 Enhancement of light activated drug therapy through combination with other therapeutic agents |
| 01/13/2011 | US20110008371 Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of antecedent hematologic disorders |
| 01/13/2011 | US20110008370 Novel use of flj25416 gene |
| 01/13/2011 | US20110008366 Inhibition of versican with sirna and other molecules |
| 01/13/2011 | US20110008363 Erythropoietin variants |
| 01/13/2011 | US20110008351 Anticomplement polypeptides of ixodes ricinus |
| 01/13/2011 | US20110008350 Extracellular targets for alzheimer's disease |
| 01/13/2011 | US20110008349 Hypoxia Induced Mitogenic Factor |
| 01/13/2011 | US20110008346 Biomarkers for cardiovascular disease |
| 01/13/2011 | US20110008333 Methods of inhibiting unwanted cell proliferation using hedgehog antagonists |
| 01/13/2011 | US20110008328 Method for controlling glucose uptake and insulin sensitivity |
| 01/13/2011 | US20110008327 Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof |